Clindamycin palmitate hydrochloride

This classification denotes a lincosamide antibiotic with the molecular formula C34H63ClN2O6S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VN9A8JM7M7, chemically known as methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-palmitate monohydrochloride but more generally known as clindamycin palmitate hydrochloride, which bears US NIH Compound Identifier 33030. European Medicines Agency schedules Clindamycin palmitate hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01343MIG. Most nations, for tariff and trade purposes, schedule clindamycin palmitate hydrochloride under HS 29419000 and SITC 54139. As of Q4 2014, CLINDAMYCIN PALMITATE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Clindamycin palmitate hydrochloride bears US NLM identifiers UMLS ID C0304311 and NCI Concept Code C61683. SMILES: CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1SC)[C@@H]([C@H](C)CL)NC(=O)[C@@H]2C[C@H](CN2C)CCC)O)O.CL.